Swiss National Bank’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-254,000
Closed -$9.99M 2644
2023
Q2
$9.99M Buy
254,000
+8,000
+3% +$282K 0.01% 901
2023
Q1
$5.99M Sell
246,000
-29,200
-11% -$639K ﹤0.01% 1142
2022
Q4
$5.89M Buy
275,200
+82,000
+42% +$1.75M ﹤0.01% 1215
2022
Q3
$3.47M Buy
193,200
+3,400
+2% +$44.6K ﹤0.01% 1501
2022
Q2
$1.83M Hold
189,800
﹤0.01% 1989
2022
Q1
$3.19M Buy
189,800
+29,700
+19% +$439K ﹤0.01% 1744
2021
Q4
$2.68M Buy
160,100
+15,000
+10% +$246K ﹤0.01% 1867
2021
Q3
$2.36M Buy
145,100
+26,600
+22% +$289K ﹤0.01% 1951
2021
Q2
$748K Sell
118,500
-43,400
-27% -$280K ﹤0.01% 2561
2021
Q1
$1M Hold
161,900
﹤0.01% 2344
2020
Q4
$1.12M Buy
+161,900
New +$1.04M ﹤0.01% 2240
2017
Q2
Sell
-42,622
Closed -$156K 2574
2017
Q1
$156K Hold
42,622
﹤0.01% 2521
2016
Q4
$206K Hold
42,622
﹤0.01% 2546
2016
Q3
$1.97M Buy
42,622
+534
+1% +$30.1K ﹤0.01% 1528
2016
Q2
$2.15M Buy
42,088
+2,900
+7% +$144K ﹤0.01% 1459
2016
Q1
$1.6M Buy
39,188
+8,500
+28% +$433K ﹤0.01% 1582
2015
Q4
$2.41M Hold
30,688
0.01% 1200
2015
Q3
$1.24M Buy
30,688
+4,400
+17% +$233K ﹤0.01% 1625
2015
Q2
$1.37M Buy
26,288
+10,088
+62% +$502K ﹤0.01% 1585
2015
Q1
$754K Buy
16,200
+800
+5% +$41.5K ﹤0.01% 1916
2014
Q4
$691K Hold
15,400
﹤0.01% 1962
2014
Q3
$600K Hold
15,400
﹤0.01% 1990
2014
Q2
$652K Buy
+15,400
New +$565K ﹤0.01% 1991

Swiss National Bank's ISEE Position: Q3 2023 in Review

Swiss National Bank sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 254,000 shares — an estimated $9.99M sold.

Swiss National Bank first reported a position in ISEE in Q2 2014 and held it in 23 quarters. The position peaked at $9.99M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Swiss National Bank reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Swiss National Bank sold 254,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $9.99M.
  • Swiss National Bank first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 23 quarters.
  • Swiss National Bank's IVERIC bio, Inc. Common Stock position peaked at $9.99M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.